These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13726268)

  • 1. Factors affecting the chain length of group A streptococci. II. Quantative M-anti-M relationships in the long chain test.
    EKSTEDT RD; STOLLERMAN GH
    J Exp Med; 1960 Oct; 112(4):687-98. PubMed ID: 13726268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the chain length of group A streptococci. I. Demonstration of a metabolically active chain-splitting system.
    EKSTEDT RD; STOLLERMAN GH
    J Exp Med; 1960 Oct; 112(4):671-86. PubMed ID: 13726267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of R antigen specific for Group A type 3 streptococci.
    LANCEFIELD RC
    J Exp Med; 1958 Sep; 108(3):329-41. PubMed ID: 13575670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long chain formation by strains of group A streptococci in the presence of homologous antiserum: a type-specific reaction.
    STOLLERMAN GH; EKSTEDT R
    J Exp Med; 1957 Sep; 106(3):345-56. PubMed ID: 13463246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the "long chain reaction" as a means for detecting type-specific antibody to group a streptococci in human sera.
    STOLLERMAN GH; SIEGEL AC; JOHNSON EE
    J Exp Med; 1959 Dec; 110(6):887-97. PubMed ID: 13834895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test.
    LANCEFIELD RC
    J Exp Med; 1957 Oct; 106(4):525-44. PubMed ID: 13475611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods.
    STOLLERMAN GH; KANTOR FS; GORDON BD
    J Exp Med; 1958 Oct; 108(4):475-91. PubMed ID: 13575679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and antigenicity of M protein released from group A, type 1 streptococcal cell walls by phage-associated lysin.
    KANTOR FS; COLE RM
    J Exp Med; 1960 Jul; 112(1):77-96. PubMed ID: 13751222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of type-specific antibodies in man following infection with group A streptococci.
    LANCEFIELD RC
    J Exp Med; 1959 Aug; 110(2):271-92. PubMed ID: 13673139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of streptococcal cell walls. VI. Effects of adjuvants on the production of type-specific antibodies to cell walls and isolated M protein.
    HAYASHI JA; WALSH G
    J Bacteriol; 1961 Nov; 82(5):736-42. PubMed ID: 13905574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to streptococcal opacity factor in human sera.
    Maxted WR; Widdowson JP; Fraser CA
    J Hyg (Lond); 1973 Mar; 71(1):35-42. PubMed ID: 4511948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time and concentration relationships in the long-chain reaction of group A streptococci in homologous antiserum and an improved method for evaluation of test results.
    HAHN JJ; COLE RM
    J Bacteriol; 1962 Jan; 83(1):85-96. PubMed ID: 13903675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studiey on the mechanism of the long chain phenomenon of group A streptococci.
    HAHN JJ; COLE RM
    J Exp Med; 1963 Apr; 117(4):583-94. PubMed ID: 13951944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro.
    HIRSCH JG; CHURCH AB
    J Exp Med; 1960 Mar; 111(3):309-22. PubMed ID: 13714578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors involved in the induction of non-specific resistance to streptococcal infection in mice by endotoxin.
    MICHAEL JG; MASSELL BF
    J Exp Med; 1962 Jul; 116(1):101-7. PubMed ID: 14473315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms.
    STOLLERMAN GH; RYTEL M; ORTIZ J
    J Exp Med; 1963 Jan; 117(1):1-17. PubMed ID: 13984363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex surveillance of Streptococcus pyogenes. III. Immunological characteristics of streptococcal resistance in blood and new aspects of type nonspecific protection.
    Kahlich R
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):61-75. PubMed ID: 772126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of precipitin analysis in agar for the study of human streptococcal infections. II. Ouchterlony and Oakley technics.
    HALBERT SP; SWICK L; SONN C
    J Exp Med; 1955 May; 101(5):557-76. PubMed ID: 14367679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel.
    FOLEY MJ; WOOD WB
    J Exp Med; 1959 Oct; 110(4):617-28. PubMed ID: 13823728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired immunity in rabbits to infection with group A type 30 hemolytic streptococcus; its relation to antibodies to the M protein.
    BAILLY MD
    J Immunol; 1950 Mar; 64(3):245-56. PubMed ID: 15412253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.